Nu Skin Enterprises (NYSE: NUS) reported Q2 EPS of $0.77, $0.08 better than the analyst estimate of $0.69. Revenue for the quarter came in at $550.1 million versus the consensus estimate of $547.68 million.

"Given our strong second-quarter financial results, we are raising our full year 2017 earnings per share outlook to $3.20 to $3.30 and reiterating our annual revenue guidance of $2.26 to $2.30 billion,\" said Mark Lawrence, chief financial officer. "For the third quarter we project revenue of $540 to $560 million and earnings per share of $0.71 to $0.76. Our new products and programs are planned for the fourth quarter with the primary focus around ageLOC LumiSpa, which we anticipate will generate approximately $100 million in sales," concluded Lawrence.

GUIDANCE:

Nu Skin Enterprises sees FY2017 EPS of $3.20-$3.30, versus the consensus of $3.12. Nu Skin Enterprises sees FY2017 revenue of $2.26-2.3 million, versus the consensus of $2.26 million.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.